CELLINK Life Sciences has partnered with Omni Life Science to make the CASY Cell Counter and Analyzer available to a wider market. CASY tracks the […]

Today, CELLINK launches the C.WASH, an innovative liquid handling system for media change in cellular assays and tipless magnetic bead washing. Among other workflows, the […]

CELLINK publishes the interim report for the period June 2020 – August 2020 as well as the report for the first 12 months. The report […]

WED, AUG 19, 2020 17:30 CET CELLINK AB (publ) (“CELLINK”) has entered into an agreement with the owners of Scienion Ag (“Scienion”), a German life science […]

CELLINK announced a distribution partnership with Kugelmeiers Ltd. to bring to market CELLINK Spheroid Kits, which package Kugelmeiers Sphericalplate 5D for forming highly standardized spheroids […]

CELLINK has collaborated with Lonza to offer a comprehensive 3-dimensional (3D) bioprinting solution designed to advance complete 3D cell culture workflows. The solution combines CELLINK’s […]

On the 20th of April, 2020, Erik Gatenholm, CEO participated on the EFN Financial news channel to discuss the listing on the Nasdaq Main Market […]

CELLINK is now publicly listed on the Nasdaq Main Market under the ticker: CLNK. This is an incredibly exciting step on our journey to change […]

As humans continue to pump more and more carbon dioxide into the atmosphere, concerns about global warming and climate change continue to grow. But what […]

“We had the vision to build an industry,” explained Erik Gatenholm. “It’s not often that we are given that opportunity, one where we see a […]

3D printing is not only used to make custom plastic objects; the technology has also been put at the service of the health industry to […]

Swedish 3D bioprinter manufacturer CELLINK has announced a strategic collaboration with microgravity manufacturing specialist Made In Space. The aim of the collaboration is to identify 3D bioprinting development opportunities […]